True malignant histiocytosis developed during chemotherapy for mediastinal immature teratoma

Human Pathology

Volumn 27, Issue 10, 1996, Pages 1099-1103

  Sasou, Shunichi ^a   Nakamura, Shin Ichi ^a   Habano, Wataru ^a   Takano, Toshikuni ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

immunohistology; malignant histiocytosis; mediastinal immature teratoma; p53 mutation

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; LYSOZYME; ONCOPROTEIN; PROTEIN P53; VIMENTIN; VINCRISTINE;

ADOLESCENT; ARTICLE; CASE REPORT; GENE MUTATION; HEPATOSPLENOMEGALY; HISTIOCYTOSIS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MALE; MEDIASTINUM TUMOR; TERATOMA; TUMOR CELL;

EID: 0029919418     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90292-0     Document Type: Article

References (23)

1. deMent SH, Eggleston JC, Spivak JL: Association between mediastinal germ cell tumors and hematologic malignancies. Report of two cases and review of the literature. Am J Surg Pathol 9:23-30, 1985
2. Nichols CR, Hoffman R, Einhorn LH, et al: Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med 102:603-609, 1985
3. deMent SH: Association between mediastinal germ cell tumors and hematologic malignancies: An update. HUM PATHOL 21:699-703, 1990
4. Chaganti RSK, Ladanyi M, Samaniego F, et al: Leukemic differentiation of a mediastinal germ cell tumor. Genes Chromosomes Cancer 1:83-87, 1989
5. Green DM, Brecher ML, Grossi M, et al: The use of different induction and maintenance chemotherapy regimens for the treatment of advanced yolk sac tumors. J Clin Oncol 1:111-116, 1983
6. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning. Isolation of high-molecular-weight DNA from mammalian cells. A Laboratory Manual, (ed 2). New York, Cold Spring Harbor Laboratory, 1989, pp 9.14-9.23
7. Dix B, Robbins P, Carrello S, et al: Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 70:585-590, 1994
8. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74:5463-5467, 1977
9. Smith LM, Sanders JZ, Kaiser RJ, et al: Fluorescence detection in automated DNA sequence analysis. Nature 321:674-679, 1986
10. Franchiano C, Reich C, Distenfeld A, et al: A clinicopathologically distinctive primary splenic histiocytic neoplasm. Demonstration of its histiocytic derivation by immunophenotypic and molecular genetic analysis. Am J Surg Pathol 12:398-404, 1988
11. Whang-Peng J, Young RC, Lee EC, et al: Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood 71:403-414, 1988
12. De Gramont A, Louvet C, Krulik M, et al: Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 Cases. Cancer 58:630-634, 1986
13. Farhi DC, Odell CA, Shurin SB: Myelodysplastic syndrome and acute myeloid leukemia after treatment for solid tumors of childhood. Am J Clin Pathol 100:270-275, 1993
14. Ladanyi M, Roy I: Mediastinal germ cell tumors and histiocytosis. HUM PATHOL 19:586-590, 1988
15. Ladanyi M, Samaniego F, Reuter VE, et al: Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst 82:221-227, 1990
16. Koo CH, Reifel J, Kogut N, et al: True histiocytic malignancy associated with a malignant teratoma in a patient with 46XY gonadal dysgenesis. Am J Surg Pathol 16:175-183, 1992
17. Lauritzen AF, Delsol G, Hansen NE, et al: Histiocytic sarcomas and monoblastic leukemias. A clinical, histologic, and immunophenotypical study. Am J Clin Pathol 102:45-54, 1994
18. Lukes RJ, Collins RD: Macrophage/Histiocyte Type Neoplasms. Tumors of the Hematopoietic System, Atlas of Tumor Pathology, Second Series, Fascicle 28:286-303, 1988
19. Ralfkiaer E, Delsol G, O'Connor NTJ, et al: Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol 160:9-17, 1990
20. Delsol G, Al Saati T, Gatter KC, et al: Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130:59-70, 1988
21. Stein H, Mason DY, Gerdes J, et al: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848-858, 1985
22. Hsu S-M, Ho Y-S, Hsu P-L: Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis. Am J Pathol 138:1389-1404, 1991
23. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453-456, 1991